In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 17th, 2009 | 28 | Yes |
Popular Name: 2-[3-[2-cyano-6-[3-(trifluoromethyl)phenyl]pyrimidin-4-yl]propylamino]-2-methyl-propanamide 2-[3-[2-cyano-6-[3-(trifluoromet…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.65 | 6.28 | -64.28 | 4 | 6 | 1 | 109 | 392.405 | 8 | ↓ |
Hi High (pH 8-9.5) | 2.65 | 5.12 | -18.7 | 3 | 6 | 0 | 105 | 391.397 | 8 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CATB-1-E | Cathepsin B (cluster #1 Of 6), Eukaryotic | Eukaryotes | 2512 | 0.28 | Binding ≤ 10μM |
CATK-1-E | Cathepsin K (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3 | 0.43 | Binding ≤ 10μM |
CATL1-1-E | Cathepsin L (cluster #1 Of 5), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
CATS-1-E | Cathepsin S (cluster #1 Of 2), Eukaryotic | Eukaryotes | 16 | 0.39 | Binding ≤ 10μM |
KCNH2-5-E | HERG (cluster #5 Of 5), Eukaryotic | Eukaryotes | 3160 | 0.28 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CATK_HUMAN | P43235 | Cathepsin K, Human | 3 | 0.43 | Binding ≤ 1μM |
CATS_HUMAN | P25774 | Cathepsin S, Human | 16 | 0.39 | Binding ≤ 1μM |
CATB_HUMAN | P07858 | Cathepsin B, Human | 2512 | 0.28 | Binding ≤ 10μM |
CATK_HUMAN | P43235 | Cathepsin K, Human | 3 | 0.43 | Binding ≤ 10μM |
CATL1_HUMAN | P07711 | Cathepsin L, Human | 10000 | 0.25 | Binding ≤ 10μM |
CATS_HUMAN | P25774 | Cathepsin S, Human | 16 | 0.39 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 3000 | 0.28 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of Matrix Metalloproteinases | |
Assembly of collagen fibrils and other multimeric structures | |
Collagen degradation | |
Degradation of the extracellular matrix | |
Endosomal/Vacuolar pathway | |
MHC class II antigen presentation | |
Trafficking and processing of endosomal TLR | |
Voltage gated Potassium channels |